Related Experiment Video
Updated: May 28, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: a tissue Doppler
Cesare Cuspidi1, Francesca Negri, Carla Sala
1Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milano, Italy. cesare.cuspidi@unimib.it
Insights
Left atrial enlargement (LAE) is common in patients without heart disease and linked to left ventricular hypertrophy (LVH) and diastolic dysfunction. Early detection of LAE can identify high-risk individuals for prevention.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Imaging
Background:
- Left atrial enlargement (LAE) is a significant risk factor for cardiovascular diseases.
- Prevalence and correlates of LAE in individuals without overt cardiac disease are not well-established.
- Echocardiography is a primary tool for assessing cardiac structure and function.
Purpose of the Study:
- To determine the prevalence of LAE in patients undergoing echocardiography for routine indications.
- To investigate the relationship between LAE, left ventricular (LV) mass, and LV diastolic function.
- To identify correlates of LAE in a cohort with preserved LV systolic function.
Main Methods:
- A comprehensive echo-Doppler examination was performed on 1104 subjects.
- Left atrial enlargement (LAE) was defined as LA volume index (LAVI) >29 ml/m(2).
- Left ventricular hypertrophy (LVH) and diastolic dysfunction were assessed using established echocardiographic parameters.
Main Results:
- 10% of subjects exhibited LAE, while 46% had LVH.
- LVH prevalence increased with higher LAVI quartiles.
- LAE was significantly associated with LV mass index, age, and diastolic function indices (E/Ei ratio, Ei).
Conclusions:
- LAE is a frequent finding in patients with preserved systolic function.
- LAE is strongly associated with LVH and diastolic dysfunction.
- Early identification of LAE may aid in stratifying cardiovascular risk and guiding preventive strategies.
Background:
Left atrial (LA) enlargement is a powerful risk factor for cardiovascular diseases; little information is available about its prevalence and correlates in subjects free of overt cardiac disease seen in echocardiographic practice.
Aim:
We evaluated the prevalence of LA enlargement (LAE) and the relationship with left ventricular (LV) mass and diastolic function in subjects with preserved LV systolic function referred to an echocardiographic study for routine clinical indications.
Methods:
1104 subjects (mean age 58 ± 16 years, 46% men, 57% hypertensives) underwent a comprehensive echo-Doppler examination. LAE and LV hypertrophy (LVH) were defined as LA volume index (LAVI) >29 ml/m(2) and LV mass index (LVMI) >50 g/h(2.7), respectively. Abnormalities of LV relaxation and LV filling were diagnosed by age-related thresholds of lateral annular velocity (Ei) and by early mitral flow velocity to Ei ratio (E/Ei) ≥16, respectively.
Results:
Overall, 10% of echocardiographic examinations fulfilled the criteria for LAE, 46% for LVH, 45% for altered LV relaxation and 5% for altered LV filling index. LVH progressively increased from 25% to 75% across LAVI quartiles. More patients in the highest quartile exhibited abnormal indexes of LV relaxation and LV filling compared with lower quartiles. In multivariate analysis, LV mass index (β = 0.408), age (β = 0.188), E/Ei ratio (β = 0.140) and Ei (β = 0.140) emerged as major correlates of LAE (p at least <0.01 for all).
Conclusions:
LAE is a frequent finding in patients with preserved systolic function seen in current practice; this abnormality is strongly related to LVH and to diastolic dysfunction. Early detection of LAE may identify patients at higher cardiovascular risk and promote appropriate prevention strategies.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
